Letters in Drug Design and Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.6 | Q4 | 18.1% | 0.301 | Q3 | 43.5% |
| 2024 | 1.6 | Q4 | 22.2% | 0.310 | Q3 | 46.7% |
| 2023 | 1.2 | Q4 | 20.0% | 0.222 | Q3 | 38.8% |
| 2022 | 1.0 | Q4 | 13.6% | 0.192 | Q3 | 36.1% |
| 2021 | 1.1 | Q4 | 33.3% | 0.213 | Q3 | 41.1% |
| 2020 | — | — | 0.223 | Q3 | 39.9% | |
| 2019 | — | — | 0.240 | Q2 | 45.2% | |
| 2018 | — | — | 0.207 | Q3 | 36.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1570-1808
ISSN
1875-628X
country
CNcoverage
2005-2026